Loading…
Reported covered position: Spec. Assist., HHS; Counsel. Sen. Budget Com.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare local coverage determinations for skin substitutes. Issues related to APNRM on Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2026 · third_quarter · Q3
Issues related to Section 301 investigation on forced labor. Issues related to Section 301 investigation on excess capacity. Issues related to Section 232 investigation on medical devices. Issues related to the USMCA trade agreement. Issues related to US/UK Pharmaceutical Agreement.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician reimbursement for orthopedic procedures. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare coverage for skin substitutes. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Source: Senate LDA
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician reimbursement for orthopedic procedures. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare coverage for skin substitutes. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician reimbursement for orthopedic procedures. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare coverage for skin substitutes. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare local coverage determinations for skin substitutes. Issues related to APNRM on Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Tax Relief for American Families and Workers Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
Tax Relief for American Families and Workers Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
Tax Relief for American Families and Workers Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to medical device supply chains. Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
Consolidated Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Consolidated Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Medical device shortage reporting provisions of S. 3799, PREVENT Pandemics Act and forthcoming MUDFA legislation.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Elijah E. Cummings Lower Drug Costs Now Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Public Health Emergency Pass-Through Payment Fairness Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. Issues related to Medicare telehealth coverage in the Centers for Medicare & Medicaid Services Interim Final Rule in response to the COVID-19 Public Health Emergency.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Preventing Essential Medical Device Shortages Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology). FDA process for pre-approval inspections during COVID.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Public Health Emergency Pass-Through Payment Fairness Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Public Health Emergency Pass-Through Payment Fairness Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Issues related to U.S. subsidiaries of foreign companies in H.R.1., For the People Act of 2019.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2026 · second_quarter · Q2
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare local coverage determinations for skin substitutes. Issues related to APNRM on Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Issues related to Section 301 investigation on forced labor. Issues related to Section 232 investigation on medical devices. Issues related to the USMCA trade agreement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2026 · first_quarter · Q1
Issues related to tariffs. Issues related to the USMCA trade agreement.
Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · fourth_quarter · Q4
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1.
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · third_quarter · Q3
Issues related to tariffs.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · second_quarter · Q2
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · first_quarter · Q1
Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations requests.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Issues related to the base erosion and anti-abuse tax. Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · fourth_quarter · Q4
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · fourth_quarter · Q4
Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · third_quarter · Q3
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Policies related to facilitating access to pediatric medical technologies.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · first_quarter · Q1
Medicare physician fee schedule, issues related to skin substitutes. Policies related to facilitating access to pediatric medical technologies.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · fourth_quarter · Q4
Issues related to medical device supply chains. Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices. CY 2024 Medicare physician fee schedule, issues related to skin substitutes. Issues related to in-office reimbursement for tympanostomy products. CMSs proposed procedural notice on Transitional Coverage for Emerging Technologies (TCET). Issues related to Medicaid reimbursement for skin substitutes. Issues related to infection prevention following childbirth.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · third_quarter · Q3
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices. CY 2024 Medicare physician fee schedule, issues related to skin substitutes. Issues related to in-office reimbursement for tympanostomy products. CMSs proposed procedural notice on Transitional Coverage for Emerging Technologies (TCET). Issues related to Medicaid reimbursement for skin substitutes. Issues related to infection prevention following childbirth.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · second_quarter · Q2
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices. CY 2023 Medicare physician fee schedule, issues related to skin substitutes. Issues related to in-office reimbursement for tympanostomy products. CMSs proposed procedural notice on Transitional Coverage for Emerging Technologies (TCET).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · first_quarter · Q1
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices, including by establishing annual adjustments based on inflation and other factors. CY 2023 Medicare physician fee schedule, issues related to skin substitutes Issues related to in-office reimbursement for tympanostomy products.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. Medical device shortage reporting.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · fourth_quarter · Q4
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · third_quarter · Q3
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · second_quarter · Q2
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · first_quarter · Q1
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Medical device shortage reporting provisions of S. 3799, PREVENT Pandemics Act and forthcoming MUDFA legislation.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · fourth_quarter · Q4
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · third_quarter · Q3
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · second_quarter · Q2
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. FDA process for pre-approval inspections during COVID. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · first_quarter · Q1
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. FDA process for pre-approval inspections during COVID.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · fourth_quarter · Q4
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology). FDA process for pre-approval inspections during COVID.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · third_quarter · Q3
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Issues related to market access for medical devices in India and China. Issues related to US tariffs on medical devices and patient access. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. Issues related to Medicare telehealth coverage in the Centers for Medicare & Medicaid Services Interim Final Rule in response to the COVID-19 Public Health Emergency.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · first_quarter · Q1
Issues related to market access for medical devices in India. Issues related to US tariffs on medical devices and patient access. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · fourth_quarter · Q4
S. 2543 - Prescription Drug Pricing Reduction Act of 2019. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Issues related to market access for medical devices in India. Issues related to US tariffs on medical devices and patient access.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · third_quarter · Q3
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Issues related to section 101 of the Patent Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · second_quarter · Q2
Issues related to U.S. subsidiaries of foreign companies and the Foreign Agents Registration Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 2669, Medical Device Safety Act.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · first_quarter · Q1
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Issues related to U.S. subsidiaries of foreign companies in H.R.1., For the People Act of 2019.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · fourth_quarter · Q4
Medicare Part D reimbursement proposals. Medicare Outpatient payment for skin substitutes. Implementation of disposable negative pressure wound therapy coverage established by "Consolidated Appropriations Act, 2016."
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · third_quarter · Q3
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · second_quarter · Q2
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52).
Issues related to market access for medical devices in India and China.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · first_quarter · Q1
Medicare Part D reimbursement proposals.
Issues related to market access for medical devices in India.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · fourth_quarter · Q4
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
Medicare Part D reimbursement proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Issues related to post-market surveillance of medical devices and unique device identifiers.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · third_quarter · Q3
Issues related to market access for medical devices in India and China. Issues related to trade agreements, including NAFTA, that impact medical technology.
Issues related to post-market surveillance of medical devices and unique device identifiers. Reauthorization of the medical device user fee agreement (H.R. 2430/S. 934, FDA Reauthorization Act of 2017), including policy issues related to FDA inspections reform (S. 404, H.R. 1736), 510(k) process (H.R. 2474, Medical Product Review Harmonization Act of 2017), and accessories (H.R. 2144, Risk-Based Classification of Accessories Act of 2017; S. 1070, Realizing Intended Safety for Certain Accessories Act of 2017.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers. Reauthorization of the medical device user fee agreement (H.R. 2430/S. 934, FDA Reauthorization Act of 2017), including policy issues related to FDA inspections reform (S. 404, H.R. 1736), 510(k) process (H.R. 2474, Medical Product Review Harmonization Act of 2017), and accessories (H.R. 2144, Risk-Based Classification of Accessories Act of 2017; S. 1070, Realizing Intended Safety for Certain Accessories Act of 2017.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code, including the House Blueprint.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · first_quarter · Q1
Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Issues related to post-market surveillance of medical devices and unique device identifiers. Reauthorization of the medical device user fee agreement, including policy issues related to FDA inspections reform (S. 404, H.R. 1736), 510(k) process, and accessories.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · fourth_quarter · Q4
Issues related to post-market surveillance of medical devices and unique device identifiers. Combination Product Regulatory Fairness Act (S. 1767). 21st Century Cures Act (P.L. 114-255).
Medical device supply chain procurement at the Veterans Health Administration
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · third_quarter · Q3
Medical device supply chain procurement at the Veterans Health Administration
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers.
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · first_quarter · Q1
Education regarding hysteroscopic tissue removal. FDA's "Public Notification of Emerging Postmarket Medical Device Signals (Emerging Signals)." Issues related to post-market surveillance of medical devices and unique device identifiers.
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2015 · fourth_quarter · Q4
Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6) and in the Consolidated Appropriations Act, 2016 (H.R. 2029).
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Education regarding hysteroscopic tissue removal. Senate FDA innovation proposals, including 3rd party QMS certification program, 510(k) clearance process, "least burdensome" rules, and treatment of combination products.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2015 · third_quarter · Q3
Education regarding hysteroscopic tissue removal; Fitzpatrick amendment #3 offered in Rules Committee on H.R. 6, the 21st Century Cures Act.
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6). CY 2016 Medicare Hospital Outpatient Proposed Rule.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2015 · second_quarter · Q2
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Provisions related to inter partes review: -- H.R. 9, Innovation Act -- S. 1137, Protecting American Talent and Entrepreneurship Act
Lobbying related to Medicare policies that promote bundled payments. Lobbying related to implementation of the ICD-10 coding system. Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2015 · first_quarter · Q1
H.R. 1078, Food and Drug Administration Safety Over Sequestration Act of 2015.
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Lobbying related to Medicare policies that promote bundled payments. Lobbying related to implementation of the ICD-10 coding system. Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018) and 21st Century Cures legislation. CY 2015 Medicare final rule for hospital outpatient prospective payment system and ambulatory surgical center payment system: Provisions related to packaging of drugs and biologicals.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · fourth_quarter · Q4
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · third_quarter · Q3
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: (1) Provisions related to reassignment of disposable negative pressure wound therapy to APC 0015; (2) Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · second_quarter · Q2
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2014 · first_quarter · Q1
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413) Consolidated Appropriations Act of 2014 (H.R. 3547)FY2015 NIH Funding levels
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · fourth_quarter · Q4
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013. SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · third_quarter · Q3
FY 2014 medical device user fees for the Food and Drug Administration.
Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · second_quarter · Q2
FY 2014 medical device user fees for the Food and Drug Administration.
Proposed regulation by the Food and Drug Administration on unique device identifiers.
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · second_quarter · RA
Medical device tax included in the Affordable Care Act; FDA regulation of medical devices; FDA user fees; Medicare reimbursement for medical devices and biologics.
Medical device tax included in the Affordable Care Act; FDA regulation of medical devices; FDA user fees; Medicare reimbursement for medical devices and biologics.
Medical device tax included in the Affordable Care Act; FDA regulation of medical devices; FDA user fees; Medicare reimbursement for medical devices and biologics.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2013 · first_quarter · Q1
FY 2013 medical device user fees for the Food and Drug Administration.
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- protect Medical Innovation Act of 2013 Medical device tax amendment to S. Con. Res. 8
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. Medicare competitive bidding for DME.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2012 · fourth_quarter · Q4
"Global Investment in American Jobs Act of 2012" (S. 3274, H.R. 5910)
FY 2013 medical device user fees for the Food and Drug Administration
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2012 · third_quarter · Q3
Review of issues discussed at the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee Panel Meeting on the Safety and Effectiveness of Metal-on-Metal Hip Arthroplasty Systems, June 27-28, 2012.
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2012 · second_quarter · Q2
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.
Provisions related to medical devices in the "Food and Drug Administration Safety and Innovation Act," P.L. 112-144.
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2012 · first_quarter · Q1
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
Legislation to reauthorize the Medical Device User Fee Act. H.R. 3847, "Safety of Untested and New Devices Act of 2012". H.R. 3209, "Premarket Predictability Act of 2011".
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2011 · fourth_quarter · Q4
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
Reform of FDA's 510(k) process for the market clearance of medical devices. Reform of FDA's pre-market approval process for Class III devices.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2011 · third_quarter · Q3
Reform of FDA's 510(k) process for the market clearance of medical devices. Reform of FDA's pre-market approval process for Class III devices.
Reauthorization of Medical Device User Fees
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2011 · second_quarter · Q2
Reform of Food and Drug Administration's 510(k) Process for the Market Clearance of Medical Devices. Reform of Food and Drug Administration's pre-market approval process for Class III devices.
Reauthorization of Medical Device User Fees. Funding for the U.S. Army Medical Research and Materiel Command.
Accountable Care Organizations
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2011 · first_quarter · Q1
Reauthorization of Medical Device User Fees.
S. 23 - "America Invents Act," Amendment Related to False Markings and Patent Reform.
H.R. 675 - Strengthening Medicare Anti-Fraud Measures Act of 2011; Medicare Debarment.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2011 · first_quarter · RR
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Issues related to tariffs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to post-market surveillance of medical devices and unique device identifiers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Tax Cuts and Jobs Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Issues related to interest deductions under IRC section 163(j) of the CARES Act (P.L. 116-136).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to Department of Treasury proposed regulation under IRC Section 382. Issues related to interest deductions under IRC section 163(j) of the CARES Act (P.L. 116-136). Issues related to the Further Consolidated Appropriations Act (P.L. 116-94).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
H.R.2207 - Protect Medical Innovation Act of 2019. S.692 - Protect Medical Innovation Act of 2019. Issues related to Department of Treasury proposed regulation under IRC Section 382.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to U.S. subsidiaries of foreign companies and the Foreign Agents Registration Act.
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and the European Union.
Medicare Part D reimbursement proposals. Medicare Outpatient payment for skin substitutes. Implementation of disposable negative pressure wound therapy coverage established by "Consolidated Appropriations Act, 2016."
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Medicare Part D reimbursement proposals. Medicare Outpatient payment for skin substitutes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and China. Issues related to trade agreements, including NAFTA, that impact medical technology.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Medicare Part D reimbursement proposals impacting low-income beneficiaries. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Issues related to market access for medical devices in India. Issues related to trade agreements, including NAFTA.
Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to post-market surveillance of medical devices and unique device identifiers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Education regarding hysteroscopic tissue removal.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Education regarding hysteroscopic tissue removal. Mobile medical technologies provisions in the 21st Century Cures legislation. Custom Device Exemption: FDA Final Guidance for Industry and Food and Drug Administration Staff.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10.
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013 SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740)Comprehensive Care Payment Innovation Act (H.R. 3796)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- protect Medical Innovation Act of 2013 Medical device tax amendment to S. Con. Res. 8
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. Medicare DMEPOS Market Pricing Program Act of 2013 (H.R. 1717). Transparency and Accountability in Medicare Bidding Act of 2013 (H.R. 2375). Medicare Drug Savings Act (H.R. 1588, S. 740).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medical device tax included in the Affordable Care Act; FDA regulation of medical devices; FDA user fees; Medicare reimbursement for medical devices and biologics.
Implementation of Section 520(b) related to custom devices, in the "Food and Drug Administration Safety and Innovation Act," P.L. 112-144. Proposed regulation by the Food and Drug Administration on unique device identifiers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of Section 520(b) related to custom devices, in the "Food and Drug Administration Safety and Innovation Act," P.L. 112-144.
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Durable Medical Equipment Proposed Rule for the Medicare Program published on July 8, 2011.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
S. 23 - "America Invents Act," Amendment Related to False Markings and Patent Reform.
H.R. 658 - "FAA Air Transportation Modernization and Safety Improvement Act ," Amendments Related to Lithium Batteries.
S. 17 - Medical Device Access and Innovation Protection Act. H.R. 436 - Medical Device Access and Innovation Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 658 - "FAA Air Transportation Modernization and Safety Improvement Act ," Amendments Related to Lithium Batteries.
Reform of Food and Drug Administration's 510(k) Process for the Market Clearance of Medical Devices.
S. 17 - Medical Device Access and Innovation Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.
Air transportation of lithium batteries; medical device tax; FDA regulation of medical devices; Medicare reimbursement; patent reform legislation; funding for medical research at the Department of Defense.